Eosinophilic Esophagitis (EoE) Treatment Market Size, Share, Growth and Trends, Report 2024-2031

Eosinophilic esophagitis (EoE) is a chronic immune-related disorder affecting the digestive system, where a high number of white blood cells called eosinophils build up in the esophagus, leading to inflammation. It's often linked to food allergies as a potential cause. Common symptoms include vomiting, stomach or chest pain, difficulty swallowing, food getting stuck in the throat, and in children, failure to thrive or grow properly.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/eosinophilic-esophagitis-treatment-market

Key Developments:

• On May 20, 2022, Swiss biotech company EsoCap AG announced its support for the first European EoE Day, which took place on May 22, 2022. This initiative was spearheaded by EUROS (European Society of Eosinophilic Oesophagitis) and AEDESEO, a Spanish association for EoE patients. The campaign, the first of its kind in Europe, aimed to raise awareness about eosinophilic esophagitis (EoE), with a focus on increasing public knowledge about its diagnosis and treatment options.

• In a related development, on April 6, 2021, Landos Biopharma, a clinical-stage biopharmaceutical company specializing in autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA) had approved their Investigational New Drug (IND) application for omilancor (BT-11). This innovative, orally administered LANCL2 agonist is being developed as a treatment for EoE, offering a novel therapeutic approach to this condition.

Market Dynamics:

Increasing adoption of innovative therapeutics

The growing adoption of innovative therapeutics is projected to drive the global market for eosinophilic esophagitis (EoE) treatments in the coming years. These therapies aim to address unmet needs in managing the disease and its complications, offering alternative or complementary treatment options for improved patient outcomes.

For example, on September 26, 2023, Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) accepted a Priority Review for the supplemental Biologics License Application for Dupixent (dupilumab) to treat children aged 1 to 11 years with EoE.

Additionally, numerous clinical trials are underway to develop novel treatments that show promising results for EoE. On October 12, 2022, Eupraxia Pharmaceuticals Inc. initiated a Phase 2 trial of EP-104IAR for adult EoE patients, a rare condition that severely affects swallowing and impacts the quality of life.

Segment Covered in Eosinophilic Esophagitis (EoE) Treatment Market:

By Treatment Type: Proton Pump Inhibitors, Omeprazole, Pantoprazole, Esomeprazole, Rabeprazole, Others, Corticosteroids, Budesonide, Fluticasone Propionate, Others.

By Route of Administration: Oral, Topical, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/eosinophilic-esophagitis-treatment-market

Key players involved in Eosinophilic Esophagitis (EoE) Treatment Market:

• Takeda Pharmaceutical Company Limited
• AstraZeneca PLC
• Regeneron Pharmaceuticals, Inc.
• Revolo Biotherapeutics
• Landos Biopharma, Inc.
• Sanofi SA
• Curia Global, Inc.
• Cadila Pharmaceuticals
• Pfizer Inc.
• Dr. Reddy's Laboratories Ltd.

*Note:

• Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.

Regional Analysis:

The Eosinophilic Esophagitis (EoE) Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Eosinophilic Esophagitis (EoE) Treatment Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:

Diabetic Retinopathy Market: https://www.datamintelligence.com/research-report/diabetic-retinopathy-market

Systemic Sclerosis Market: https://www.datamintelligence.com/research-report/systemic-sclerosis-market

Pressure Ulcers Market: https://www.datamintelligence.com/research-report/pressure-ulcers-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.